Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Conference abstract · 3 Jul 2013Exact title match Review article · Jul 2020 Evaluation of the Progression of Hybridoma Technology: Methods, Applications, Advantages and Drawbacks
technologies have been used to produce antibodies in a number of laboratories. Since 1975, hybridoma technology has become the most widely used technique to generate antigen specific monoclonal antibodies (MAbs…
Review article · 25 Oct 2013 38 Years of Hybridoma Technology as a Source of Analytical Tools for Immunodiagnostics of Infectious Diseases. Some Contributions Developed in Cuba to Improve the Original Procedures and Future Prospects
George Köhler and César Milstein, with a remarkable article on hybridoma technology published in Nature, opened a new era in biology with enormous implications for analysis in biomedicine and biotechnology
Opinion · 25 Jul 2021 Hybridoma Technology: An Overview
Short communication · 27 Oct 2020 Relevance of Hybridoma Technology to the Covid-19 immunization era: Monoclonal Antibodies' methodologies, applications, pros, and cons
Coronavirus disease 2019 (Covid-19) has claimed over 2.5 million lives around
Review article · 23 Mar 2017 HYBRIDOMA TECHNOLOGY: A REVIEW
Hybridoma innovation is the strategy in which expansive amount of indistinguishable antibodies
Short communication · 30 Dec 2024 Advancements in Cancer Research: Implementing Hybridoma Technology's Potential
Commentary · 26 Apr 2021 Monoclonal Antibodies
epitopes on an antigen. Murine mAbs were the first generation of mAbs created via hybridoma technology, however because of their murine origin, they might induce an anti-mouse antibody response
Review article · 3 Mar 2021 Antibody Drug Conjugates (ADC)-The Current Status
Antibody-drug conjugates (ADCs) aim to take advantage of the specificity of
Review article · 7 Mar 2020 The Best IgG Subclass for the Development of Therapeutic Monoclonal Antibody Drugs and their Commercial Production: A Review
Most of the clinically available monoclonal antibody (mAbs) drugs are Immunoglobulin G
Review article · 29 Mar 2019 A NOVEL THERAPEUTIC APPROACH USING BIOTECHNOLOGY ON PHARMACEUTICAL PRODUCTS
Objective: The present review focus on biotechnology medicines, therapeutic agents obtained from
Conference abstract · 3 Jul 2013 Impurity profiling of oseltamivir by using spectrophotometric techniques
full use of the natural products of the human humoral immune system. The hybridoma technology developed by Kohler and Milstein promised to solve these problems. This technology makes it possible ... same antibody…
Conference abstract · 8 Nov 2017 Immunological detection of antibiotic residues using antibody engineering
There are diversified antibody generation platforms/methods (e.g., Polyclonal antibody (pAb), Cell engineering antibodies—hybridoma technology, recombinant antibdy (rAb)). Different species of antibodies e.g. chicken…
Conference abstract · 25 Mar 2022 A Rapid Immunodiagnostic Test for Active Tuberculosis.
Freund's adjuvant. The monoclonal antibodies (mAbs) were developed using these antigens via hybridoma technology. Hybridoma clones were screened and positive clones were selected for further experiments. The mAbs were
Conference abstract · 30 Jun 2021 Comparison of the Conventional and Modern Approachs in the Development and Manufacturing of Monoclonal Antibodies
field of medicine. There are different manufacturing techniques of monoclonal antibodies such as hybridoma technology which is the most conventional method, phage display technology, transgenic mouse method and other…
Review article · 3 May 2019 Monoclonal Antibodies Present New Opportunities in Disease Diagnosis and Treatment
production of MAbs by hybridoma technology was discovered in 1975 by Georges Kohler of West Germany and Cesar Milstein of Argentina. Who developed a technique to fuse splenocyte cells (separated
Review article · 12 Dec 2019 Development of Therapeutic Antibody Technology And Recent Perspectives For Leukemia-Lymphoma Treatment
significant role for treatment of leukemia-lymphoma at the current time. The therapeutic Mab technology development from murine (mouse origin) to fully human resulted in low immunogenicity and high quality ... lymphoma…
Conference abstract · 11 Aug 2014 Bionano Sensor in Molecular Imaging and Fusion Technology
Sequestering agents, in vitro and in vivo labeling ? Fusion of nanosensors with immunological agents- Hybridoma technology ? Scanners and image fusion: PET- CT, SPECT-CT, MRI-CT/USG ? Technique optimization, Quality
Conference abstract · 22 Aug 2019 Immunoassay of S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH): Methylation index as a biomarker for diseased or healthy status
against active small biomolecules with weak immunogenicity, such as SAM and SAH, using traditional hybridoma technology. The antigens and antibodies described here will contribute to the development of immunoassays
Short communication · 21 Mar 2019 Short Communication on Study of Immunology
Antibodies can be produced in specialized cells via a system now popularly often called Hybridoma technology. Vaccines aid the body admire and battle infectious diseases. Traditional vaccines use weakened
Conference abstract · 18 Jul 2018 The impact of nanotherapeutics in transforming the medicine
commercialization of nanotechnology-based medical products. Diversified approaches based on synthetic, recombinant, hybridoma and phage display technologies have been undertaken to fabricate a variety of nanoparticulate…
Article · 3 May 2019 Carrier Erythrocytes (Red Blood Cells) for Delivery of Biopharmaceuticals
include products manufactured using both ‘new’ technologies (recombinant DNA and monoclonal antibody/hybridoma) and ‘old’ technologies (fermentation, nonrecombinant cell culture derived proteins, vaccines, and other…
Conference abstract · 27 Oct 2014 Regulatory challenges in biosimilars
essential part of modern pharmacotherapy. These comprise proteins derived from recombinant DNA technology and hybridoma technique. Examples include biological proteins (cytokines, hormones, and clotting factors)…
Conference abstract Analysis of phage displayed antibody fragment: Pros and cons of phage ELISA and RISE methods
antibodies raised by vaccination is connected with cloning and selecting best binders by hybridoma or display technology. One of gold standards in this approach is antibody phage display technology which
Conference abstract Construction, expression and characterisation of a single chain variable fragment using phage display technology to recognize MCF-7 breast cancer cells in the E. coli periplasm
breast cancer carcinoma cell line was constructed from the C3A8 hybridoma using phage display technology. The scFv coding sequence was cloned in frame with the pIII phage coat protein

